Genotoxicity of etoposide: greater susceptibility of MLL than other target genes.

[1]  M. Relling,et al.  The FASEB Journal express article 10.1096/fj-03-0638fje. Published online Nov. 20, 2003. Etoposide induces chimeric Mll gene fusions , 2022 .

[2]  N. Osheroff,et al.  Reciprocal DNA topoisomerase II cleavage events at 5′-TATTA-3′ sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing , 2003, Oncogene.

[3]  P. Nowell,et al.  Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Y. Pommier,et al.  Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints. , 2001, Biochemistry.

[5]  B. Roe,et al.  DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. , 2000, Human molecular genetics.

[6]  S. Raimondi,et al.  Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia , 2000, Genes, chromosomes & cancer.

[7]  M. Stanulla,et al.  Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus , 1997, Leukemia.

[8]  M. Stanulla,et al.  Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. , 1996, Blood.

[9]  C. Felix,et al.  Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. , 1995, Cancer research.

[10]  E. Soeda,et al.  Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. , 1995, Nucleic acids research.

[11]  M. Cole,et al.  Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation. , 1993, Cancer research.